Sugi Predict

Sugi Predict / Compounds / SCHEMBL1242215

SCHEMBL1242215

SCHEMBL1242215

COC(=O)C(=O)N(Cc1ccc(C(C)(C)C)cc1)c1ccc(-c2ccc(C#N)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 1/20 0.49
▸ PTGES O14684 2/20 0.48
▸ ALOX5 P09917 2/20 0.48
▸ EPHX2 P34913 1/20 0.48
▸ NR1H4 Q96RI1 3/20 0.42
▸ LTB4R2 Q9NPC1 1/20 0.42
▸ MEN1 O00255 1/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ CACNA1H O95180 1/20 0.41
▸ PPARA Q07869 1/20 0.41
▸ MAPKAPK2 P49137 2/20 0.40
▸ PDK1 Q15118 1/20 0.39
▸ PDK2 Q15119 1/20 0.39
▸ PDK3 Q15120 1/20 0.39
▸ PDK4 Q16654 1/20 0.39
▸ CHRM2 P08172 2/20 0.39
▸ CHRM1 P11229 2/20 0.39
▸ CHRM3 P20309 2/20 0.39
▸ MLYCD O95822 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1241404 0.91 PTGES (0.56) KIF11PTGESALOX5EPHX2NR1H4
SCHEMBL1239731 0.87 PTGES (0.54) KIF11PTGESALOX5EPHX2NR1H4
SCHEMBL13581167 0.86 PTGES (0.64) PTGESALOX5NR1H4LTB4R2MEN1
SCHEMBL12953600 0.86 PTGES (0.52) PTGESALOX5NR1H4LTB4R2
SCHEMBL1239699 0.86 PTGES (0.52) PTGESALOX5NR1H4NPC1MAPT
SCHEMBL1242134 0.85 PTGES (0.51) PTGESALOX5EPHX2NR1H4LTB4R2
SCHEMBL12890078 0.85 PTGES (0.51) PTGESALOX5NR1H4LTB4R2PDK1
SCHEMBL1242692 0.85 PTGES (0.51) PTGESALOX5NR1H4LTB4R2PDK1
SCHEMBL1242205 0.85 PTGES (0.51) PTGESALOX5NR1H4MEN1NPC1
SCHEMBL1241356 0.85 PTGES (0.51) PTGESALOX5NR1H4LTB4R2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8633245-B2 PAI-1 inhibitor INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2014-01-21 — — US disclosed
US-7884234-B2 N-[4-(tert-butyl)benzyl]-N-[4 -(trifluoromethoxy)biphenyl-3-yl]oxamic Acid; Inhibitors of plasminogen activator inhibitor-1 (PAI-1); thrombogenesis, fibrogenesis, accumulation of visceral fat, cell proliferation, angiogenesis INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2011-02-08 — — US disclosed
US-20090215899-A9 N-Phenyloxamide derivatives INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2009-08-27 — — US disclosed
EP-2072498-A1 N-PHENYLOXAMIDIC ACID DERIVATIVE Institute of Medicinal Molecular Design, Inc. (JP) 2009-06-24 — — EP disclosed
US-20080249175-A1 N-Phenyloxamide derivatives INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2008-10-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249175-A1 N-Phenyloxamide derivatives SERPINE1, SERPINH1, F12 KIF11 3293/4885PTGES 465/4885ALOX5 445/4885
US-20090215899-A9 N-Phenyloxamide derivatives SERPINE1, SERPINH1, F12 KIF11 3293/4885PTGES 465/4885ALOX5 445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.